These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31807142)
1. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid. Wegner RE; Abel S; Horne ZD; Hasan S; Colonias A; Verma V Lung Cancer Manag; 2019 Aug; 8(3):LMT14. PubMed ID: 31807142 [TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer. Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630 [TBL] [Abstract][Full Text] [Related]
3. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer. Newman NB; Sherry AD; Byrne DW; Osmundson EC J Radiat Oncol; 2019 Jun; 8(2):239-248. PubMed ID: 31402969 [TBL] [Abstract][Full Text] [Related]
5. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer. Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862 [TBL] [Abstract][Full Text] [Related]
6. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness. Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer. Verma V; Hasan S; Wegner RE; Abel S; Colonias A Radiother Oncol; 2019 Feb; 131():145-149. PubMed ID: 30773182 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival. Dohopolski MJ; Glaser SM; Vargo JA; Balasubramani GK; Beriwal S J Gastrointest Oncol; 2017 Oct; 8(5):766-777. PubMed ID: 29184680 [TBL] [Abstract][Full Text] [Related]
9. Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer. Wang SC; Ting WC; Chang YC; Yang CC; Lin LC; Ho HW; Chu SS; Lin YW Front Oncol; 2020; 10():814. PubMed ID: 32547949 [No Abstract] [Full Text] [Related]
10. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277 [TBL] [Abstract][Full Text] [Related]
11. Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma. Lo H; Abel S; Finley G; Weksler B; Colonias A; Wegner RE Thorac Cancer; 2020 Feb; 11(2):305-310. PubMed ID: 31860940 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer. Mitera G; Swaminath A; Rudoler D; Seereeram C; Giuliani M; Leighl N; Gutierrez E; Dobrow MJ; Coyte PC; Yung T; Bezjak A; Hope AJ J Oncol Pract; 2014 May; 10(3):e130-6. PubMed ID: 24643574 [TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer. Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607 [TBL] [Abstract][Full Text] [Related]
14. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer. Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135 [TBL] [Abstract][Full Text] [Related]
15. Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer. Poon DMC; Lam D; Wong KCW; Chu CM; Cheung M; Mo F; Suen J; Ng CF; Chan ATC Curr Oncol; 2021 Dec; 29(1):27-37. PubMed ID: 35049677 [TBL] [Abstract][Full Text] [Related]
17. Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases. Gao RW; Olivier KR; Park SS; Davis BJ; Pisansky TM; Choo R; Kwon ED; Karnes RJ; Harmsen WS; Stish BJ Adv Radiat Oncol; 2019; 4(2):314-322. PubMed ID: 31011676 [TBL] [Abstract][Full Text] [Related]
18. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database. Xiang M; Heestand GM; Chang DT; Pollom EL Radiother Oncol; 2020 Feb; 143():101-107. PubMed ID: 32044168 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung. Wegner RE; Abel S; Colonias A Lung Cancer Manag; 2020 Apr; 9(3):LMT32. PubMed ID: 32774465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]